Equities

Adicon Holdings Ltd

Adicon Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)8.38
  • Today's Change-0.08 / -0.95%
  • Shares traded277.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adicon Holdings Ltd is an investment holding company principally engaged in the provision of independent clinical laboratory (ICL) services. The Company primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The Company's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The Company is also engaged in the sales of medical testing equipment. The Company principally conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)3.56bn
  • Net income in HKD253.28m
  • Incorporated2008
  • Employees5.71k
More ▼

Institutional shareholders

1.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Apr 20249.01m1.24%
Grandeur Peak Global Advisors LLCas of 31 Jan 20244.00m0.55%
TIAA-CREF Investment Management LLCas of 31 Mar 2024102.50k0.01%
BlackRock Fund Advisorsas of 09 May 202466.00k0.01%
BlackRock Advisors (UK) Ltd.as of 09 May 202449.50k0.01%
State Street Global Advisors Ltd.as of 09 May 202435.00k0.01%
BlackRock Institutional Trust Co. NAas of 09 May 202422.00k0.00%
Federated Equity Management Company of Pennsylvaniaas of 31 Dec 20230.000.00%
BlackRock Advisors LLCas of 31 Dec 20230.000.00%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.